SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-040626
Filing Date
2023-08-09
Accepted
2023-08-09 16:18:10
Documents
55
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q asmb-20230630.htm   iXBRL 10-Q 2289809
2 EX-31.1 asmb-ex31_1.htm EX-31.1 22828
3 EX-32.1 asmb-ex32_1.htm EX-32.1 12366
  Complete submission text file 0000950170-23-040626.txt   7383133

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT asmb-20230630_def.xml EX-101.DEF 127364
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT asmb-20230630_cal.xml EX-101.CAL 39776
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT asmb-20230630_pre.xml EX-101.PRE 233305
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT asmb-20230630.xsd EX-101.SCH 41190
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT asmb-20230630_lab.xml EX-101.LAB 324726
49 EXTRACTED XBRL INSTANCE DOCUMENT asmb-20230630_htm.xml XML 1447586
Mailing Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BLVD. FOURTH FLOOR SOUTH SAN FRANCISCO CA 94080 (833) 409-4583
ASSEMBLY BIOSCIENCES, INC. (Filer) CIK: 0001426800 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35005 | Film No.: 231155440
SIC: 2834 Pharmaceutical Preparations